Robitussin Chesty Cough Medicine

Robitussin is a globally recognized brand of cough medicine known for its line of expectorants and cough suppressants. The brand was originally developed by the A.H. Robins Company in the United States during the mid-20th century, specifically formulated by Dr. A.H. Robins. Over the decades, the brand has passed through several major pharmaceutical hands, including Wyeth and Pfizer.

Currently, Robitussin is owned by Haleon, a British multinational consumer healthcare company. Haleon was formed through a joint venture between GSK and Pfizer's consumer healthcare businesses and subsequently spun off as an independent entity in 2022. While the brand has American roots, its manufacturing is now distributed across various global facilities to meet international demand, with major production sites in the United Kingdom, United States, and Europe.